All In MedTech

Device Trial Radar · NCT04970212

Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures

Pivotal Clinical Study to Establish the Safety and Effectiveness of the Use of BioTraceIO Lite for Assessment of Tissue Damage Following Liver Tissue Ablation Procedures

Last checked: Nov 20, 2026Latest source record: Apr 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

65

Actual

Start

Sep 24, 2021

Primary completion

Oct 8, 2022

Study completion Oct 8, 2022

Sponsor

Lead sponsor
Techsomed Medical Technologies LTDNot on our public-company list
Sponsor type
Industry
First posted
Jul 21, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Clinical study planned to demonstrate that the BioTraceIO Lite, available post-procedure, is effective at estimating the area of tissue damage as measured on 24-hour post-procedure (T=24hrs) CECT scan and that it is safe, based on an assessment of device-related Adverse Events. Multi-center (up to 6 investigational sites) prospective single-arm clinical investigation 50 evaluable subjects total stratified by cancer type (primary hepatocellular carcinoma vs. secondary liver metastases).

Conditions

  • Carcinoma, Hepatocellular
  • Metastatic Liver Cancer

Interventions

  • BioTraceIO LiteDevice

    The BioTraceIO software will analyze the ultrasound images, and provide the physician with an estimated tissue damage map.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety - Adverse EventsTime frame: 1 year
  2. Effectiveness - DICETime frame: 1 year

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona

  • Stanford Medicine

    Stanford, California

  • Massachusetts General Hospital

    Boston, Massachusetts

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.